DOCSLIB.ORG

Neuroanatomy and Neurobiology of Sleep

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Neuroanatomy and Neurobiology of Sleep Neuroanatomy and neurobiology of sleep Mary J. Morrell, Paolo Palange, Patrick Levy and Wilfried De Backer The neurobiology of sleep electrical potentials. He termed these recordings electroencephalograms and by Sleep is a dynamic process involving the mid-1930s the cyclical patterns complex neural activation. In 1929 the associated with NREM sleep had been psychiatrist Hans Berger established that categorised. The first observations of REM brain activity was different during sleep occurred in the 1950s (Aserinsky et al., wakefulness and sleep by recording cortical 1953). Understanding of the control mechanisms of NREM and REM sleep continues to develop. Key points The neural regulation of wakefulness and N arousal from sleep Neurons of the reticular Wakefulness is maintained by activating system are central to the activation of the ascending reticular regulation of wakefulness. Specifically, there activating system involving several are two ascending pathways: one, a dorsal neurotransmitters including route from the cholinergic laterodorsal and glutamate, acetylcholine and the pedunculopontine tegmental nuclei, monoamines. activates thalamic neurons to promote EEG N NREM sleep onset is associated with activity via glutamatergic thalamocortical a reduction in activation of the projections (Saper et al., 2005). The ventral ascending reticular activating system route through the hypothalamus includes and an increase in neural activity the aminergic arousal system that originates within the ventrolateral pre-optic area, from the brainstem with serotonergic anterior hypothalamus and basal (dorsal raphe nuclei), noradrenergic (locus forebrain. coeruleus), histaminergic (tuberomammillary nucleus) and N REM sleep is triggered by activation of dopaminergic (ventral periaqueductal grey) cholinergic neurons in the neurons (Horner, 2008). Cortical activation laterodorsal and pedunculopontine during wakefulness is also influenced by tegmental nuclei. The suppression of orexinergic (hypocretin) neurons originating motor activity in REM sleep is in the hypothalamus, and cholinergic generated by glutamate-mediated neurons from the basal forebrain (fig. 1a). activation of descending medullary During wakefulness these pathways allow reticular formation. sensory information to be transmitted to N Cycles of NREM and REM sleep areas of the association cortex via the alternate throughout the night in a thalamic gate. predictable manner. The neural regulation of NREM and REM N Ageing is associated with difficulty in sleep The transition between wakefulness maintaining sleep and more frequent and sleep occurs through a process of arousals. reciprocal inhibition between arousal- and sleep-promoting neurons by way of a ‘‘flip-flop’’ ERS Handbook: Respiratory Sleep Medicine 1 a) 10 1 9 Olfactory 11 Upper bulb 13 airway 12 14 2 3 • Histaminergic 8 • 7 Serotonergic • Noradrenergic 6 4 5 • Cholinergic • Orexinergic b) • Glutaminergic Upper airway • GABAergic 1 Pineal c) 2 Pons Upper 3 Medulla oblongata airway 4 Spinal cord 5 Pituitary 6 Tuberomammillary nucleus 7 Preoptic area 8 Hypothalamus 9 Corpus callosum 10 Cerebral cortex 11 Hippocampus 12 Thalamus 13 Midbrain 14 Cerebellum Figure 1. a)Wakefulness-, b) NREM sleep- and c) REM sleep-generating neuronal systems in the rat brain. Descending projections to the respiratory and hypoglossal motor neurons in the medulla are also shown. Solid lines indicate active neuronal groups and projections, respectively. Dashed lines and decreased symbol size indicate suppressed activity. Lines terminating with an arrow indicate excitatory projections, lines terminating with an oval indicate inhibitory projections and lines terminating in a diamond indicate mixed excitatory and inhibitory projections for acetylcholine. The progressive suppression of hypoglossal motor output to genioglossus muscle from wakefulness to NREM and REM sleep is illustrated by reduced line thickness. Figure adapted from Horner (2008), with permission from the publisher. 2 ERS Handbook: Respiratory Sleep Medicine Awake REM Stage 1 Stage 2 Stage 3 Stage 4 0 123456 Hours of recording Figure 2. A typical overnight sleep hypnogram illustrating the sleep cycles that occur overnight in a young male. REM sleep is seen approximately every 90 min and there are occasional brief arousals from sleep. switch (McGinty et al., 2000). This is an NREM sleep is conventionally divided into all-or-nothing process that prevents the three or four stages according to the occurrence of intermediate conscious guidelines laid out by the American states. At sleep onset, neurons in the Academy of Sleep Medicine in 2007. These ventrolateral pre-optic area (VLPO), stages approximately represent the depth of anterior hypothalamus and basal forebrain sleep and are analysed using standardised are activated and inhibit the arousal criteria (see chapter 5). systems detailed previously. In particular, the VLPO neurons containing the In adults sleep is most often initiated inhibitory neurotransmitters c-aminobutyric through NREM sleep and is marked by acid (GABA) and galanin, project to (and synchronisation of EEG activity (for further inhibit) the wake-promoting regions of the description of the EEG that defines the ascending reticular system (Sherin et al., stages of sleep see chapter 5). The overnight 1998) and the descending brainstem sleep patterns in a healthy young adult are arousal neurons (fig. 1b). shown in figure 2. NREM predominates early in the night with episodes of REM REM sleep occurs with activation of sleep occurring in approximately 90-min cholinergic neurons in the laterodorsal and intervals. The 90-min NREM–REM cycle is pedunculopontine tegmental nuclei. This repeated approximately three to six times cholinergic activation occurs when during the night, and the duration of REM withdrawal of the aminergic arousal systems sleep increases as the night progresses. The (noradrenergic neurons in the locus preferential occurrence of NREM sleep coeruleus and serotonergic neurons in the (particularly slow-wave sleep) early in the dorsal raphe nuclei) produces disinhibition. night is coincidental with sleep This causes the release of acetylcholine, homeostasis, while the predominance of which triggers the increased neural activity REM sleep later in the night is thought to be that is a feature of REM sleep. Suppression associated with the circadian rhythm of core of motor activity, the other marker of REM body temperature. sleep, is generated by glutamate-mediated activation of descending medullary reticular Sleep cycles in ageing Sleep is essential for formation relay neurons (fig. 1c). The life in humans. Total sleep deprivation over activity of these neurons is inhibitory to 2–3 weeks impairs thermal regulation, spinal motor neurons via the release of energy balance and immune function, glycine and to a lesser extent GABA eventually causing death. The requirements (Reinoso-Suarez et al., 2001). for sleep vary with age. In infants, active (REM) sleep dominates in the first 1– The cycle of wakefulness and sleep The 2 months of life. After 3 months NREM transition from wake to sleep can be difficult sleep begins to dominate, and by 5 yrs of to determine as there are typically brief age adult sleep stages are established. The periods of drowsiness with transient bursts percentage of REM sleep is reduced to adult of wakefulness before sleep consolidation. levels by 10 yrs of age. ERS Handbook: Respiratory Sleep Medicine 3 35 increasing age may be due to a reduction in the amplitude of delta waves detected on 30 ●● the EEG recordings, meaning that stage 3–4 ● ● sleep is not documented despite the 25 ● ● ● presence of delta waves. Alternatively, ● ● disrupted synchronisation of neuronal ● ● 20 ● ● ● ● ● activation may occur as a result of an age- ● ● ● ● ● ● ● ● ●● ● ● ● related decline in the neural systems that 15 ● ● ● ● ● ● regulate sleep. An increase in the lighter ● ● 10 ● r=0.852 sleep partially compensates for the loss of Arousal/hour of sleep deep sleep (Van Cauter et al., 2000) but 5 p<0.00001 there is also a reduction in the number of sleep spindles and K complexes. The 0 0 10 20 30 40 50 60 70 80 duration of REM sleep tends to remain Age yrs constant throughout adulthood (Landolt et al., 1996), although a reduction in the Figure 3. The influence of age on the number of proportion of REM sleep has been reported arousals (awakenings o3 s) per hour of sleep. by some (Van Cauter et al., 2000). Reproduced with permission from Boselli et al. (1998), with permission from the publisher. Further reading In adults, optimal sleep duration varies. N Aserinsky E, et al. (1953). Regularly Sleep restriction to ,5 h a night causes a occurring periods of eye motility, and reduction in psychomotor vigilance (Dinges concomitant phenomena, during sleep. et al., 1997), a decline in mood and Science; 118: 273–274. motivation and a worse performance on N Boselli M, et al. (1998). Effect of age on memory tests. Increasing sleep opportunity EEG arousals in normal sleep. Sleep; 21: up to 10 h a night improves cognitive 361–367. function. Most estimates suggest that 7.5– N Dijk DJ, et al. (2000). Contribution of 8.5 h of sleep are required for optimal circadian physiology and sleep home- performance. ostasis to age-related changes in human sleep. Chronobiol Int; 17: 285–311. Ageing influences sleep cycles, with older N Dinges DF, et al. (1997). Cumulative people reporting that they experience sleepiness, mood disturbance, and psy- difficulty in maintaining sleep and increased chomotor
Load more

Recommended publications
  • Ventrolateral Preoptic Nucleus (VLPO) Role in Turning the Ascending Arousal System Off During Sleep
    Progressing Aspects in Pediatrics and Neonatology DOI: 10.32474/PAPN.2020.02.000146 ISSN: 2637-4722 Mini Review Ventrolateral Preoptic Nucleus (VLPO) Role in Turning the Ascending Arousal System Off During Sleep Behzad Saberi* Medical Research, Esfahan, Iran *Corresponding author: Behzad Saberi, Medical Research, Esfahan, Iran Received: June 02, 2020 Published: July 24, 2020 Mini Review References Coordinated manner of action of the projections from monoaminergic cell groups, cholinergic and orexin neurons, 1. Saper, Clifford B, Scammell, Thomas E Lu (2005) Hypothalamic regulation of sleep and circadian rhythms. Nature 437 (7063): 1257- produces arousal. Turning this arousal system off would result in 1263. producing sleep. There is an important role for the Ventrolateral 2. Chou Thomas C, Scammell Thomas E, Gooley Joshua J, Gaus Stephanie, Preoptic Nucleus (VLPO) to inhibit the arousal circuits during sleep. Saper Clifford B Lu (2003) “Critical Role of Dorsomedial Hypothalamic VLPO neurons are sleep active neurons [1-3]. Also, these neurons Nucleus in a Wide Range of Behavioral Circadian Rhythms”. The Journal of Neuroscience 23 (33): 10691-10702. contain GABA and Galanin as inhibitory neurotransmitters. Such 3. Phillips AJK, Robinson PA (2007) A Quantitative Model of Sleep-Wake neurons receive afferents from monoaminergic systems. VLPO Dynamics Based on the Physiology of the Brainstem Ascending Arousal lesions would cause fragmented sleep and insomnia. System. Journal of Biological Rhythms 22(2): 167-179. VLPO has two groups of neurons: One group located in the 4. Brown RE, McKenna JT (2015) Turning a Negative into a Positive: Ascending GABAergic Control of Cortical Activation and Arousal. Front. core of the VLPO and its neurons project to the tuberomammillary Neurol 6: pp.135.
    [Show full text]
  • Scale-Free Dynamics of the Mouse Wakefulness and Sleep Electroencephalogram Quantified Using Wavelet-Leaders
    Article Scale-Free Dynamics of the Mouse Wakefulness and Sleep Electroencephalogram Quantified Using Wavelet-Leaders Jean-Marc Lina 1,2,3, Emma Kate O’Callaghan 1,4 and Valérie Mongrain 1,4,* 1 Research Centre and Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montréal (CIUSSS-NIM), 5400 Gouin West blvd., Montreal, QC H4J 1C5, Canada 2 Centre de Recherches Mathématiques, Université de Montréal, C.P. 6128, succ. Centre-Ville, Montreal, QC H3C 3J7, Canada; [email protected] 3 École de Technologie Supérieure, 1100 rue Notre-Dame Ouest, Montreal, QC H3C 1K3, Canada 4 Department of Neuroscience, Université de Montréal, C.P. 6128, succ. Centre-Ville, Montreal, QC H3C 3J7, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-514-338-2222 (ext. 3323) Received: 14 August 2018; Accepted: 11 October 2018; Published: 20 October 2018 Abstract: Scale-free analysis of brain activity reveals a complexity of synchronous neuronal firing which is different from that assessed using classic rhythmic quantifications such as spectral analysis of the electroencephalogram (EEG). In humans, scale-free activity of the EEG depends on the behavioral state and reflects cognitive processes. We aimed to verify if fractal patterns of the mouse EEG also show variations with behavioral states and topography, and to identify molecular determinants of brain scale-free activity using the ‘multifractal formalism’ (Wavelet-Leaders). We found that scale-free activity was more anti-persistent (i.e., more different between time scales) during wakefulness, less anti-persistent (i.e., less different between time scales) during non-rapid eye movement sleep, and generally intermediate during rapid eye movement sleep.
    [Show full text]
  • An Electrophysiological Marker of Arousal Level in Humans
    RESEARCH ARTICLE An electrophysiological marker of arousal level in humans Janna D Lendner1,2*, Randolph F Helfrich3,4, Bryce A Mander5, Luis Romundstad6, Jack J Lin7, Matthew P Walker1,8, Pal G Larsson9, Robert T Knight1,8 1Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, United States; 2Department of Anesthesiology and Intensive Care Medicine, University Medical Center Tuebingen, Tuebingen, Germany; 3Hertie-Institute for Clinical Brain Research, Tuebingen, Germany; 4Department of Neurology and Epileptology, University Medical Center Tuebingen, Tuebingen, Germany; 5Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, United States; 6Department of Anesthesiology, University of Oslo Medical Center, Oslo, Norway; 7Department of Neurology, University of California, Irvine, Irvine, United States; 8Department of Psychology, University of California, Berkeley, Berkeley, United States; 9Department of Neurosurgery, University of Oslo Medical Center, Oslo, Norway Abstract Deep non-rapid eye movement sleep (NREM) and general anesthesia with propofol are prominent states of reduced arousal linked to the occurrence of synchronized oscillations in the electroencephalogram (EEG). Although rapid eye movement (REM) sleep is also associated with diminished arousal levels, it is characterized by a desynchronized, ‘wake-like’ EEG. This observation implies that reduced arousal states are not necessarily only defined by synchronous oscillatory activity. Using intracranial and surface EEG recordings in four independent data sets, we demonstrate that the 1/f spectral slope of the electrophysiological power spectrum, which reflects the non-oscillatory, scale-free component of neural activity, delineates wakefulness from propofol *For correspondence: anesthesia, NREM and REM sleep. Critically, the spectral slope discriminates wakefulness from [email protected] REM sleep solely based on the neurophysiological brain state.
    [Show full text]
  • Deconstructing Arousal Into Wakeful, Autonomic and Affective Varieties
    Neuroscience Letters xxx (xxxx) xxx–xxx Contents lists available at ScienceDirect Neuroscience Letters journal homepage: www.elsevier.com/locate/neulet Review article Deconstructing arousal into wakeful, autonomic and affective varieties ⁎ Ajay B. Satputea,b, , Philip A. Kragelc,d, Lisa Feldman Barrettb,e,f,g, Tor D. Wagerc,d, ⁎⁎ Marta Bianciardie,f, a Departments of Psychology and Neuroscience, Pomona College, Claremont, CA, USA b Department of Psychology, Northeastern University, Boston, MA, USA c Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, USA d The Institute of Cognitive Science, University of Colorado Boulder, Boulder, USA e Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA, USA f Department of Radiology, Harvard Medical School, Boston, MA, USA g Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA ARTICLE INFO ABSTRACT Keywords: Arousal plays a central role in a wide variety of phenomena, including wakefulness, autonomic function, affect Brainstem and emotion. Despite its importance, it remains unclear as to how the neural mechanisms for arousal are or- Arousal ganized across them. In this article, we review neuroscience findings for three of the most common origins of Sleep arousal: wakeful arousal, autonomic arousal, and affective arousal. Our review makes two overarching points. Autonomic First, research conducted primarily in non-human animals underscores the importance of several subcortical Affect nuclei that contribute to various sources of arousal, motivating the need for an integrative framework. Thus, we Wakefulness outline an integrative neural reference space as a key first step in developing a more systematic understanding of central nervous system contributions to arousal.
    [Show full text]
  • Estradiol Action at the Median Preoptic Nucleus Is Necessary And
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.29.223669; this version posted July 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Estradiol Action at the Median Preoptic Nucleus is Necessary and Sufficient for Sleep Suppression in Female rats Smith PC, Cusmano DM, Phillips DJ, Viechweg SS, Schwartz MD, Mong JA Support: This work was supported by Grant 1F30HL145901 (to P.C.S.), Grant F31AG043329 (to D.M.C.) and Grant R01HL85037 (to J.A.M.). The authors are responsible for this work; it does not necessarily represent the official views of the NIA, NHLBI, or NIH. Disclosure: The authors have nothing to disclose Conflicts of Interest: The authors have no conflicts of interest. Abstract To further our understanding of how gonadal steroids impact sleep biology, we sought to address the mechanism by which proestrus levels of cycling ovarian steroids, particularly estradiol (E2), suppress sleep in female rats. We showed that steroid replacement of proestrus levels of E2 to ovariectomized female rats, suppressed sleep to similar levels as those reported by endogenous ovarian hormones. We further showed that this suppression is due to the high levels of E2 alone, and that progesterone did not have a significant impact on sleep behavior. We found that E2 action within the Median Preoptic Nucleus (MnPN), which contains estrogen receptors (ERs), is necessary for this effect; antagonism of ERs in the MnPN attenuated the E2-mediated suppression of both non- Rapid Eye Movement (NREM) and Rapid Eye Movement (REM) sleep.
    [Show full text]
  • MWT Review Paper.Qxp 12/30/2004 8:46 AM Page 123
    MWT review paper.qxp 12/30/2004 8:46 AM Page 123 REVIEW PAPER The Clinical Use of the MSLT and MWT Donna Arand, Ph.D1, Michael Bonnet, Ph.D2, Thomas Hurwitz, M.D3, Merrill Mitler, Ph.D4, Roger Rosa, Ph.D5 and R. Bart Sangal, M.D6 1 Kettering Medical Center, Dayton, OH, 2Dayton Veteran’s Affairs Medical Center and Wright State University, Dayton, OH, 3Minneapolis Veteran’s Affairs Medical Center and University of Minnesota, Minneapolis, MN, 4National Institute of Neurological Disorders & Stroke Neuroscience Center, Bethesda, MD, 5National Institute for Occupational Safety and Health, Washington, DC, 6Sleep Disorders Institute, Troy, MI Citation: Review by the MSLT and MWT Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. SLEEP 2005;28(1):123-144. 1.0 INTRODUCTION ness and to assess the database of evidence for the clinical use of the MSLT and MWT. EXCESSIVE SLEEPINESS IS DEFINED AS SLEEPINESS OCCURRING IN A SITUATION WHEN AN INDIVIDUAL 2.0 BACKGROUND WOULD BE EXPECTED TO BE AWAKE AND ALERT. It is a chronic problem for about 5% of the general population,1, 2 and it 2.1 History of the Development of MSLT and MWT is the most common complaint evaluated by sleep disorder cen- Initially, definitions involving sleep onset were based on ters.1, 3 The most common causes of sleepiness include partial sleep deprivation, fragmented sleep and medication effects. behavioral observations that often depended on features such as Sleepiness is also associated with sleep disorders such as sleep lack of movement, unresponsiveness, snoring, etc.
    [Show full text]
  • Pharmacological Management of Disrupted Sleep Due to Methamphetamine Use: a Literature Review
    Journal of Psychology and Clinical Psychiatry Literature Review Open Access Pharmacological management of disrupted sleep due to Methamphetamine use: a literature review Abstract Volume 11 Issue 5 - 2020 Objective: To review the literature on pharmacological management of disrupted sleeping Jagdeep Kaur,1 Kawish Garg2 patterns due to Methamphetamine use. 1Clinical Director of MAT Services, Keystone Behavioral Health Data sources: A PubMed search of human studies published in English through July 2020 Services, USA 2 was conducted using the broad search terms “Methamphetamine” and “Sleep”. Medical Director of Sleep Medicine, Geisinger Holy Spirit, USA Study selection: 105 articles were identified and reviewed; 2 studies met the inclusion Correspondence: Kawish Garg, Medical Director of Sleep criteria. Medicine, Geisinger Holy Spirit, 550 North 12th St Lemoyne, PA 17043, USA, Tel 717-975-8585, Email Data extraction: Study design, sample size, medications dose and duration, and sleep related outcomes were reviewed. Received: September 10, 2020 | Published: September 23, 2020 Data synthesis: This is some evidence for Modafinil and Mirtazapine for disrupted sleep due to Methamphetamine use, however it is limited by small sample size of the studies. Conclusion: Treatment of disrupted sleep due to Methamphetamine use, remains challenging. Modafinil and mirtazapine appear to show promise, but further research is warranted before making any evidence-based recommendations. Keywords: methamphetamine, sleep Abbreviations: NSDUH, national survey on
    [Show full text]
  • Drugs, Sleep, and the Addicted Brain
    www.nature.com/npp PERSPECTIVE OPEN Drugs, sleep, and the addicted brain Rita J. Valentino1 and Nora D. Volkow 1 Neuropsychopharmacology (2020) 45:3–5; https://doi.org/10.1038/s41386-019-0465-x The neurobiology of sleep and substance abuse interconnects, opioid-withdrawal signs, including the hyperarousal and insomnia such that alterations in one process have consequences for the associated with withdrawal [9]. Notably, α2-adrenergic antagonists other. Acute exposure to drugs of abuse disrupts sleep by (lofexidine and clonidine) that inhibit LC discharge are clinically affecting sleep latency, duration, and quality [1]. With chronic used for the attenuation of opioid and alcohol withdrawal to administration, sleep disruption becomes more severe, and during reduce peripheral symptoms from sympathetic activation, such as abstinence, insomnia with a negative effect prevails, which drives tachycardia, as well as central symptoms, such as insomnia, drug craving and contributes to impulsivity and relapse. Sleep anxiety, and restlessness. Their utility in suppressing symptoms impairments associated with drug abuse also contribute to during protracted abstinence, such as insomnia, along with its cognitive dysfunction in addicted individuals. Further, because associated adverse consequences (irritability, fatigue, dysphoria, sleep is important in memory consolidation and the process of and cognitive impairments) remains unexplored. extinction, sleep dysfunction might interfere with the learning of Like LC–NE neurons, the raphe nuclei (including the dorsal non-reinforced drug associations needed for recovery. Notably, raphe nucleus—DRN) serotonin (5-HT) neurons modulate sleep current medication therapies for opioid, alcohol, or nicotine and wakefulness through widespread forebrain projections. The addiction do not reverse sleep dysfunctions, and this may be an role of this system in sleep is complex.
    [Show full text]
  • The Substantia Nigra the Tuberomammillary Nucleus
    Neurotransmitter Receptors in the Substantia Nigra & the Tuberomammillary Nucleus Coronal Section Coronal Section Coronal Section Substantia Nigra From Pedunculopontine Nucleus Pars Compacta From Dorsal Raphe From Striatum (Caudate/Putamen) Substantia Nigra Hypothalamus Hypothalamus Substantia Nigra From Striatum (Caudate/Putamen) 5-HT R The Substantia Nigra 1B M Muscarinic AChR The substantia nigra (SN) is an area of deeply pigmented cells in the 5 ACh+ midbrain that regulates movement and coordination. Neurons of the nAChR α4α5α6β2 SN are divided into the substantia nigra pars compacta (SNc) and the substantia nigra pars reticulata (SNr). Neurons of the SNc produce Dopamine, which stimulates movement. In contrast, GABAergic neurons of the SNr can stimulate or inhibit movement depending on GABA+ GABAergic Neuron the input signal. GluR6:KA2 D2R mGluR5 mGluR3 From Subthalamic Nucleus GABA-A-R The SN controls movement by functioning as part of the basal ganglia, α3γ2 5-HT1BR Adenosine A1R CB1R a network of neurons that is critical for motion and memory. Along with GABA-B-R1 α GABA+ 4 Astrocyte GABA-B-R2 the SN, the basal ganglia consists of the putamen, the subthalamic EAAT1/GLAST-1 D R + + nAChR α3γ2 1 Neurokinin A /GABA nucleus, the caudate, and the globus pallidus, which is further divided GABA-A-R mGluR7 NK3R NK3R GABA-B-R1 µ-Opioid receptor into the globus pallidus interna (GPi) and the globus pallidus externa EAAT3 GABA-A-R α3γ3/γ2 GABA-B-R2 (GPe). Excluding the caudate, which is thought to be involved in EAAT4 D R learning and memory, the nuclei of the basal ganglia receive signals 2 D R α α β from the cerebral cortex when there is intent to coordinate movement.
    [Show full text]
  • Potential Brain Neuronal Targets for Amphetamine-, Methylphenidate
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 14128–14133, November 1996 Neurobiology Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat (immediate-early geneyprotooncogeneyanterior hypothalamic nucleusystriatumydopaminergic system) JIANG-SHENG LIN*, YIPING HOU, AND MICHEL JOUVET De´partementde Me´decineExpe´rimentale, Institut National de la Sante´et de la Recherche Me´dicaleUnite´52, Centre National de la Recherche Scientifique ERS 5645, Faculte´deMe´decine, Universite´Claude Bernard, 8 avenue Rockefeller, 69373 Lyon, France Communicated by Jean-Pierre Changeux, Institut Pasteur, Paris, France, August 29, 1996 (received for review July 29, 1996) ABSTRACT Much experimental and clinical data suggest expression of IEGs occurs in the brain, c-fos is strongly expressed that the pharmacological profile of modafinil, a newly dis- in various specific cerebral areas following different stimuli, such covered waking substance, differs from those of amphetamine as electrical or pharmacological stimulation, stress, or sleep and methylphenidate, two classical psychostimulants. The deprivation (8–15). Thus, visualization of c-fos could serve as a brain targets on which modafinil acts to induce wakefulness, sensitive indicator of gene activation in individual target neurons however, remain unknown. A double-blind study using the activated following a given stimulus. protooncogene c-fos as experimental marker in the cat was, We have, therefore, developed Fos immunocytochemical pro- therefore, carried out to identify the potential target neurons cedures in both the rat and cat to visualize the potential targets of modafinil and compare them with those for amphetamine of modafinil and amphetamine in the central nervous system.
    [Show full text]
  • Reidun Ursin Changing Concepts on the Role of Serotonin in the Regulation of Sleep and Waking
    Reidun Ursin Changing concepts on the role of serotonin in the regulation of sleep and waking The story of serotonin and sleep has been developing for more than 50 years, from the discovery in the 1950s that it had a role in brain function and in EEG synchronization. In parallel, the areas of sleep research and neurochemistry have seen enormous developments. The concept of serotonin as a sleep neurotransmitter was based on the effects of lesions of the brainstem raphe nuclei and the effects of serotonin depleting drugs in cats. The description of the firing pattern of the dorsal raphe nuclei changed this concept, initially to the entirely opposite view of serotonin as a waking transmitter. More recently, there has emerged a more complex view on the role of serotonin as a modulator of both waking and sleep. The effects of serotonin on sleep and waking may depend on which neurons are firing, their projection site, which postsynaptic receptors are present at this site, and, not the least, on the functional state of the system and the organism at a particular moment. Christopher A. Lowry, Andrew K. Evans, Paul J. Gasser, Matthew W. Hale, Daniel R. Staub and Anantha Shekhar Topographic organization and chemoarchitecture of the dorsal raphe nucleus and the median raphe nucleus The role of serotonergic systems in regulation of behavioral arousal and sleep-wake cycles is complex and may depend on both the receptor subtype and brain region involved. Increasing evidence points toward the existence of multiple topographically organized subpopulations of serotonergic neurons that receive unique afferent connections, give rise to unique patterns of projections to forebrain systems, and have unique functional properties.
    [Show full text]
  • The Paraventricular Nucleus of the Thalamus Is Recruited by Both
    REVIEW ARTICLE published: 03 April 2014 BEHAVIORAL NEUROSCIENCE doi: 10.3389/fnbeh.2014.00117 The paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin/hypocretin signaling in this thalamic nucleus in drug-seeking behavior Alessandra Matzeu*, Eva R. Zamora-Martinez and Rémi Martin-Fardon Molecular and Cellular Neuroscience Department, The Scripps Research Institute, La Jolla, CA, USA Edited by: A major challenge for the successful treatment of drug addiction is the long-lasting Christopher V. Dayas, University of susceptibility to relapse and multiple processes that have been implicated in the Newcastle, Australia compulsion to resume drug intake during abstinence. Recently, the orexin/hypocretin Reviewed by: (Orx/Hcrt) system has been shown to play a role in drug-seeking behavior. The Orx/Hcrt Andrew Lawrence, Florey Neuroscience Institutes, Australia system regulates a wide range of physiological processes, including feeding, energy Robyn Mary Brown, Florey metabolism, and arousal. It has also been shown to be recruited by drugs of abuse. Neuroscience Institutes, Australia Orx/Hcrt neurons are predominantly located in the lateral hypothalamus that projects to *Correspondence: the paraventricular nucleus of the thalamus (PVT), a region that has been identified as a Alessandra Matzeu, Molecular and “way-station” that processes information and then modulates the mesolimbic reward and Cellular Neuroscience Department, The Scripps Research Institute, 10550 extrahypothalamic stress systems. Although not thought to be part of the “drug addiction North Torrey Pines Road, SP30-2120, circuitry”,recent evidence indicates that the PVT is involved in the modulation of reward La Jolla, CA 92037, USA function in general and drug-directed behavior in particular.
    [Show full text]